ReviewBiological trace element research2026
Recent Advances in the Treatment of Thyroid Pathologies with Selenium-Containing Compounds, Nanoparticles and Nanocomplexes Based on Selenium and Selenoproteins.
Review in Biological trace element research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid diseases are a pressing issue in modern medicine, making it crucial to develop new pharmacological agents with effective therapeutic properties. This review analyzes the latest research on the role of various compounds of the essential trace element selenium in maintaining normal thyroid hormone function. In recent decades, numerous studies have been published demonstrating the diverse therapeutic properties of selenium compounds of various origins, demonstrating the effectiveness of this trace element in combating diseases of various etiologies. It is known that the thyroid gland, an important endocrine organ, regulates the hormonal balance of the key hormones thyroxine and triiodothyronine, and the enzymes that play a key role in this regulation are selenium-containing deiodinases. This review presents the latest data on this regulation, as well as the role of other selenoproteins in mitigating thyroid pathological processes. In addition, the latest developments in nanoselenium-based drugs are presented and the mechanisms for regulating various thyroid pathologies using selenium-containing nanoparticles and nanocomplexes are described. The role of organic and inorganic selenium-based drugs is also described. Thus, the information presented in this review allows us to understand the latest trends in the development of new selenium-based drugs for maintaining normal thyroid function.
Indexed as
Identifiers
42496838What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.